Impact of silver-containing wound dressings on bacterial biofilm viability and susceptibility to antibiotics during prolonged treatment

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 12, 2010, Pages 5120-5131

  Kostenko, Victoria ^a   Lyczak, Jeffrey ^b   Turner, Katherine ^c   Martinuzzi, Robert John ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b SHIRE   (United States)

^c Attogen Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; SILVER; TOBRAMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL; BIOFILM; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; ESCHERICHIA COLI; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; WOUND DRESSING;

ANTI-BACTERIAL AGENTS; BANDAGES; BIOFILMS; CIPROFLOXACIN; MICROBIAL VIABILITY; PSEUDOMONAS AERUGINOSA; SILVER COMPOUNDS; TIME FACTORS; TOBRAMYCIN; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; WOUND INFECTION;

EID: 78649666092     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00825-10     Document Type: Article

References (43)

1. Berra, L., F. Curto, G. Li Bassi, P. Laquerriere, A. Baccarelli, and T. Kolobow. 2006. Antibacterial-coated tracheal tubes cleaned with the mucus shaver: a novel method to retain long-term bactericidal activity of coated tracheal tubes. Intensive Care Med. 32:888-893. (Pubitemid 43781371)
2. Berra, L., F. Curto, G. Li Bassi, P. Laquerriere, B. Pitts, A. Baccarelli, and T. Kolobow. 2008. Antimicrobial-coated endotracheal tubes: an experimental study. Intensive Care Med. 34:1020-1029.
3. Bjarnsholt, T., K. Kirketerp-Møller, S. Kristiansen, R. Phipps, A. K. Nielsen, P. O. Jensen, N. Høiby, and M. Givskov. 2007. Silver against Pseudomonas aeruginosa biofilms. APMIS 115:921-928.
4. Ceri, H., M. E. Olson, C. Stremick, R. R. Read, D. Morck, and A. Buret. 1999. The Calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J. Clin. Microbiol. 37:1771-1776.
5. Chaw, K. C., M. Manimaran, and F. E. Tay. 2005. Role of silver ions in destabilization of intermolecular adhesion forces measured by atomic force microscopy in Staphylococcus epidermidis biofilms. Antimicrob. Agents Chemother. 49:4853-4859.
6. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing. Document M100-S15. CLSI, Wayne, PA.
7. Damm, C., and H. Munstedt. 2008. Kinetic aspects of the silver ion release from antimicrobial polyamide/silver nanocomposites. Appl. Phys. A 91:479-486.
8. Davis, S. C., A. Cazzaniga, E. Welsh, W. H. Eaglstein, and P. M. Mertz. 2008. Microscopic and physiological evidence for biofilm-associated wound colonization in vivo. Wound Rep. Reg. 16:23-29.
9. Dunn, K., and V. Edwards-Jones. 2004. The role of Acticoat with nanocrystalline silver in the management of burns. Burns 30(Suppl. 1):1-9.
10. Fux, C. A., J. W. Costerton, P. S. Stewart, and P. Stoodley. 2005. Survival strategies of infectious biofilms. Trends Microbiol. 13:34-40.
11. Hall, R. E., G. Bender, and R. E. Marquis. 1987. Inhibitory and cidal antimicrobial actions of electrically generated silver ions. J. Oral Maxillofac. Surg. 45:779-784.
12. Heggers, J., R. E. Goodheart, J. Washington, L. McCoy, E. Carino, T. Dang, P. Edgar, C. Maness, and D. Chinkes. 2005. Therapeutic efficacy of three silver dressings in an infected animal model. J. Burn Care Rehabil. 26:53-56. (Pubitemid 40105195)
13. Hill, K. E., S. Malic, R. McKee, T. Rennison. K. G. Harding, D. W. Williams, and D. W. Thomas. 8 April 2010, posting date. An in vitro model of chronic wound biofilms to test wound dressings and assess antimicrobial susceptibilities. J. Antimicrob. Chemother. doi:10.1093/jac/dkq105.
14. Holder, I. A., P. Durkee, A. P. Supp, and S. T. Boyce. 2003. Assessment of a silver-coated barrier dressing for potential use with skin grafts on excised burns. Burns 29:445-448.
15. Hom, D. B., G. Adams, M. Koreis, and R. Maisel. 1999. Choosing the optimal wound dressing for irradiated soft tissue wounds. Otolaryngol. Head Neck Surg. 121:591-598.
16. Huang, Y., X. Li, Z. Liao, G. Zhang, Q. Liu, J. Tang, Y. Peng, X. Liu, and Q. Luo. 2007. A randomized comparative trial between Acticoat and SD-Ag in the treatment of residual burn wounds, including safety analysis. Burns 33:161-166. (Pubitemid 46201863)
17. Keren, I., N. Kaldalu, A. Spoering, Y. Wang, and K. Lewis. 2004. Persister cells and tolerance to antimicrobials. FEMS Microbiol. Lett. 230:13-18.
18. Klueh, U., V. Wagner, S. Kelly, A. Johnson, and J. D. Bryers. 2000. Efficacy of silver-coated fabric to prevent bacterial colonization and subsequent device-based biofilm formation. J. Biomed. Mater. Res. 53:621-631.
19. Lansdown, A. B., A. Williams, S. Chandler, and S. Benfield. 2005. Silver absorption and antimicrobial efficacy of silver dressings. J. Wound Care 14:155-160.
20. Lansdown, A. B. 2002. Silver. I. Its antibacterial properties and mechanism of action. J. Wound Care 11:125-130.
21. Leaper, D. J. 2006. Silver dressings: their role in wound management. Int. Wound J. 3:282-294.
22. Meaume, S., D. Vallet, M. N. Morere, and L. Teot. 2005. Evaluation of a silver-releasing hydroalginate dressing in chronic wounds with signs of local infection. J. Wound Care 14:411-419.
23. Modak, S., and C. L. Fox. 1985. Synergistic action of silver sulfadiazine and sodium piperacillin on resistant Pseudomonas aeruginosa in vitro and in experimental burn wound infections. J. Trauma 25:27-31.
24. Modak, S. M., L. Sampath, and C. L. Fox. 1988. Combined topical use of silver sulfadiazine and antibiotics as a possible solution to bacterial resistance in burn wounds. J. Burn Care Rehabil. 9:359-363.
25. Olson, M. E., B. G. Harmon, and M. H. Kollef. 2002. Silver-coated endotracheal tubes associated with reduced bacterial burden in the lungs of mechanically ventilated dogs. Chest 121:863-870.
26. Park, H. J., J. Y. Kim, J. Kim, J. H. Lee, J. S. Hahn, M. B. Gu, and J. Yoon. 2009. Silver-ion-mediated reactive oxygen species generation affecting bactericidal activity. Water Res. 43:1027-1032.
27. Parsons, D., M. Walker, and P. G. Bowler. 2006. Silver: clarifying the claims. Ostomy Wound Manage. 52:34-41.
28. Percival, S. L., R. Bowler, and E. J. Woods. 2008. Assessing the effect of an antimicrobial wound dressing on biofilms. Wound Repair Regen. 16:52-57.
29. Qin, Y. 2005. Silver-containing alginate fiber and dressings. Int. Wound J. 2:172-176.
30. Rai, M., A. Yadav, and A. Gade. 2009. Silver nanoparticles as a new generation of antimicrobials. Biotechnol. Adv. 27:76-83.
31. Rhoads, D. D., R. D. Wolcott, and S. L. Percival. 2008. Biofilms in wounds: management strategies. J. Wound Care 17:502-508.
32. Ricketts, G. R., E. J. Lowburry, J. C. Lawrence, M. Hall, and M. D. Wilkins. 1970. Mechanism of prophylaxis by silver compounds against infection of burns. Br. Med. J. i:444-446.
33. Riley, D. K., D. C. Classen, L. E. Stevens, and J. P. Burke. 1995. A large randomized clinical trial of a silver-impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. Am. J. Med. 98:349-356.
34. Roe, D., B. Karandikar, N. Bonn-Savage, B. Gibbins, and J. B. Roullet. 2008. Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. J. Antimicrob. Chemother. 61:869-876.
35. Russell, A. D., and W. B. Hugo. 1994. Antimicrobial activity and action of silver. Prog. Med. Chem. 31:351-370.
36. Sauer, K., A. K. Camper, G. D. Ehrlich, J. W. Costerton, and D. G. Davies. 2002. Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J. Bacteriol. 184:1140-1154.
37. Shahverdi, A. R., A. Fakhimi, H. R. Shahverdi, and S. Minaian. 2007. Synthesis and effect of silver nanoparticles on the antimicrobial activity of different antibiotics against Staphylococcus and Escherichia coli. Nanomedicine 3:168-171.
38. Sibbald, R. G., H. Orsted, G. S. Schultz, P. Coutts, and D. Keast. 2003. Preparing the wound bed 2003: focus on infection and inflammation. Ostomy Wound Manag. 49:24-51.
39. Strohal, R., M. Schelling, M. Takacs, W. Jurecka, U. Gruber, and F. Offner. 2005. Nanocrystalline silver dressings as an efficient anti-MRSA barrier: a new solution to an increasing problem. J. Hosp. Infect. 60:226-230.
40. Thomas, S., and P. McCubbin. 2003. A comparison of the antimicrobial effects of four silver-containing dressings on three organisms. J. Wound Care 12:101-107.
41. Totaro, P., and M. Rambaldini. 2009. Efficacy of antimicrobial activity of slow release silver nanoparticles dressing in post-cardiac surgery mediastinitis. Interact. Cardiovasc. Thorac. Surg. 8:153-154.
42. Wright, J. B., K. Lam, A. Buret, M. E. Olson, and R. E. Burrell. 2002. Early healing events in a porcine model of contaminated wounds: effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing. Wound Rep. Reg. 10:141-151.
43. Yin, H. Q., R. Langford, and R. E. Burrell. 1999. Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing. J. Burn Care Rehabil. 20:195-200.